Filing Details
- Accession Number:
- 0001181431-13-009830
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2013-02-14 17:51:37
- Reporting Period:
- 2012-12-31
- Filing Date:
- 2013-02-14
- Accepted Time:
- 2013-02-14 17:51:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1544116 | Durata Therapeutics Inc. | DRTX | Pharmaceutical Preparations (2834) | 871247903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553593 | W. Michael Dunne | C/O Durata Therapeutics, Inc. 200 South Wacker Drive, Suite 2550 Chicago IL 60606 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-07-24 | 2,000 | $9.00 | 13,220 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
